Free Trial

National Vision (EYE) Competitors

National Vision logo
$26.37 +0.81 (+3.17%)
Closing price 04:00 PM Eastern
Extended Trading
$26.38 +0.00 (+0.02%)
As of 06:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EYE vs. NVST, STVN, IRTC, BLCO, GKOS, TMDX, SLNO, LIVN, WRBY, and INSP

Should you be buying National Vision stock or one of its competitors? The main competitors of National Vision include Envista (NVST), Stevanato Group (STVN), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), Glaukos (GKOS), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), LivaNova (LIVN), Warby Parker (WRBY), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry.

National Vision vs. Its Competitors

Envista (NYSE:NVST) and National Vision (NASDAQ:EYE) are both mid-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, institutional ownership, media sentiment, dividends, valuation and profitability.

National Vision has lower revenue, but higher earnings than Envista. National Vision is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.55B1.25-$1.12B$0.3260.09
National Vision$1.89B1.11-$28.50M-$0.18-146.50

Envista presently has a consensus target price of $21.08, suggesting a potential upside of 9.60%. National Vision has a consensus target price of $24.73, suggesting a potential downside of 6.23%. Given Envista's higher probable upside, analysts plainly believe Envista is more favorable than National Vision.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
2 Sell rating(s)
10 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.24
National Vision
1 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.45

Envista has a net margin of 2.11% compared to National Vision's net margin of -0.75%. Envista's return on equity of 4.84% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
Envista2.11% 4.84% 2.68%
National Vision -0.75%3.56%1.49%

Envista has a beta of 1.01, suggesting that its share price is 1% more volatile than the S&P 500. Comparatively, National Vision has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500.

In the previous week, National Vision had 2 more articles in the media than Envista. MarketBeat recorded 8 mentions for National Vision and 6 mentions for Envista. National Vision's average media sentiment score of 0.86 beat Envista's score of 0.24 indicating that National Vision is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Envista
1 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
National Vision
1 Very Positive mention(s)
5 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Envista beats National Vision on 9 of the 15 factors compared between the two stocks.

Get National Vision News Delivered to You Automatically

Sign up to receive the latest news and ratings for EYE and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EYE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

EYE vs. The Competition

MetricNational VisionCONS PD IndustryStaples SectorNASDAQ Exchange
Market Cap$2.09B$31.16B$15.46B$10.46B
Dividend YieldN/A2.75%3.25%4.79%
P/E Ratio-146.5036.6717.4827.07
Price / Sales1.112.0347.60190.44
Price / Cash15.6215.1814.3730.17
Price / Book2.547.886.946.69
Net Income-$28.50M$1.23B$678.09M$276.03M
7 Day Performance-6.32%-2.92%-2.21%-1.13%
1 Month Performance14.70%-7.53%-2.24%6.49%
1 Year Performance162.65%13.41%-2.38%34.41%

National Vision Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EYE
National Vision
2.282 of 5 stars
$26.37
+3.2%
$24.73
-6.2%
+154.6%$2.09B$1.89B-146.5013,411Positive News
NVST
Envista
3.9632 of 5 stars
$20.64
-1.0%
$20.92
+1.4%
+5.4%$3.46B$2.51B64.5012,300
STVN
Stevanato Group
N/A€24.57
-5.4%
N/A+25.5%€7.44B€1.19B45.505,521
IRTC
iRhythm Technologies
1.2518 of 5 stars
$175.74
+0.1%
$172.17
-2.0%
+208.7%$5.64B$591.84M-59.982,000Analyst Forecast
BLCO
Bausch + Lomb
1.82 of 5 stars
$14.87
-2.2%
$15.60
+4.9%
-26.3%$5.38B$4.79B-19.0613,500
GKOS
Glaukos
4.2945 of 5 stars
$86.64
-0.9%
$122.00
+40.8%
-34.9%$5.01B$383.48M-52.51780Analyst Forecast
TMDX
TransMedics Group
3.3135 of 5 stars
$113.93
-1.5%
$125.40
+10.1%
-20.6%$3.94B$441.54M59.03210Analyst Forecast
SLNO
Soleno Therapeutics
4.365 of 5 stars
$58.45
-1.3%
$115.09
+96.9%
+16.5%$3.15B$32.66M-14.1230
LIVN
LivaNova
2.338 of 5 stars
$52.63
-1.4%
$59.71
+13.5%
-3.5%$2.91B$1.25B-13.532,900
WRBY
Warby Parker
2.3227 of 5 stars
$25.41
-3.1%
$24.75
-2.6%
+41.4%$2.76B$771.32M-362.953,780Positive News
INSP
Inspire Medical Systems
4.846 of 5 stars
$76.36
-0.3%
$154.43
+102.2%
-64.3%$2.26B$802.80M44.141,246Analyst Forecast

Related Companies and Tools


This page (NASDAQ:EYE) was last updated on 10/13/2025 by MarketBeat.com Staff
From Our Partners